BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 11:27:00 AM | Browse: 1230 | Download: 1367
 |
Received |
|
2013-06-28 10:41 |
 |
Peer-Review Started |
|
2013-06-28 16:33 |
 |
To Make the First Decision |
|
2013-07-05 18:35 |
 |
Return for Revision |
|
2013-07-08 17:12 |
 |
Revised |
|
2013-07-20 00:55 |
 |
Second Decision |
|
2013-08-16 19:44 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-08-16 23:31 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-10-10 15:42 |
 |
Publish the Manuscript Online |
|
2013-12-18 16:32 |
Category |
Biochemistry & Molecular Biology |
Manuscript Type |
Minireviews |
Article Title |
Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders
|
Manuscript Source |
Invited Manuscript |
All Author List |
Libia Vega and Guillermo Elizondo |
Funding Agency and Grant Number |
|
Corresponding Author |
Guillermo Elizondo, PhD, Departamento de Biología Celular, CINVESTAV-IPN, Zacatenco, Av. IPN 2508, CP 07360, México city, México. gazuela@cinvestav.mx |
Key Words |
Aryl hydrocarbon receptor; Cell proliferation; Apoptosis; Immunity; Cancer |
Core Tip |
The goal of the present review was to discuss the role of the aryl hydrocarbon receptor (AhR) in cell proliferation and immune responses, and to highlight the potential for AhR to serve as a therapeutic target for cancer and immune diseases. |
Publish Date |
2013-12-18 16:32 |
Citation |
Vega L, Elizondo G. Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders. World J Pharmacol 2013; 2(4): 107-114 |
URL |
http://www.wjgnet.com/2220-3192/full/v2/i4/107.htm |
DOI |
http://dx.doi.org/10.5497/wjp.v2.i4.107 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345